Gregory D. Perry
Chief Financial Officer, ImmunoGen Inc.
Companies
- Merus N.V.Chief financial officer Jun 15, 2023 to now1
- Kala Pharmaceuticals (United States)Board member Mar 2, 2018 to now2
- Merus N.V.Board member Jan 2, 2020 to Jun 12, 20233
- Finch Therapeutics Group, Inc.Chief financial officer Mar 18, 2021 to Feb 28, 20224
- Carisma Therapeutics Inc.Chief financial officer Feb 5, 2014 to Feb 27, 20155
- INVIVO THERAPEUTICS HOLDINGS CORP.Chief financial officer Sep 30, 2013 to Jan 2, 20146
- ImmunoGen Inc.Chief financial officer Jan 12, 2009 to Sep 11, 20137
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kala Pharmaceuticals (United States) KALA13,344 shares8$2.6K at $0.19Jun 15, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 15, 2025Granted 2,450 shares of Kala Pharmaceuticals (United States)8
- Jun 11, 2024Granted 1,400 shares of Kala Pharmaceuticals (United States)9
- Jun 22, 2023Granted 1,100 shares of Kala Pharmaceuticals (United States)10
- Jun 22, 2023Granted 5,856 shares of Kala Pharmaceuticals (United States)10
- May 31, 2023Granted 1,738 shares of Kala Pharmaceuticals (United States)11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARMerus N.V., Chief financial officer
- 2
- 3SEC EDGARMerus N.V., Board member
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jun 12, 2024
- 10SEC EDGARForm 4 filed Jun 23, 2023
- 11SEC EDGARForm 4 filed Jun 2, 2023